No AIDS cure in the near future

David Ho discusses promising vaccine approaches, improved therapies, and remaining obstacles

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

AIDS treatments are improving, but no cure is likely in this decade, David D. Ho told a New York audience after accepting a newly created prize for medical research. Ho, director and chief executive officer of the Aaron Diamond AIDS Research Center at Rockefeller University, received the Lewis and Jack Rudin New York Prize for Medical Research on Thursday (October 30) at the New York Academy of Medicine and delivered a lecture titled, HIV in 2010: What Will the Science Allow?

It was a theme he took on reluctantly, he said, given the difficulty of making predictions. The prize awarded to Ho was in recognition of his research on subjects including antiretroviral therapies, which have dramatically extended lifespans for AIDS patients by limiting viral multiplication.

Barring major new findings, Ho said, "I do not see us going from being able to control viral replication to a cure." But he added ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jack Lucentini

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development